Sun Pharmaceuticals, Lupin top picks: Mehraboon Irani

Sun Pharmaceuticals and Lupin are top picks, says Mehraboon Irani, Nirmal Bang Securities.

Irani told CNBC-TV18, "One needs to be very selective in pharmaceutical pack. My top bets have been Sun  Pharmaceuticals and Lupin. But in the midcaps Glenmark is a Dark Horse because of the development which you just  read out, this type of things as far as Glenmark goes has consistently been happening over the last few years - would  definitely be Glenmark and possibly a Biocon. So I would look at these four stocks quite positively as far as the overall  pharmaceutical pack goes."
Sun Pharmaceuticals price-to-earnings (P/E) ratio was 55.59. The latest book value of the company is Rs 78.30 per  share. At current value, the price-to-book value of the company was 9.49. The dividend yield of the company was  0.57%.